Topical Pharmaceutical composition comprising, based on the total weight of the composition (a) 0.01 to 0.2% by weight of Mometasone furoate (b) 5 to 18% by weight of hexylene glycol.(c) 20 to 40 Weight percent of water and (d) 25 to 70% by weight of an oil Phase； and its use to Treat or prevent psoriasis, atopic dermatitis, among others.

• 收藏
• 分享

专利权人:

ALMIRALL; S.A.

发明人:

EVERS FRITJOF,MALLWITZ HENNING,MEYER RICARDA,WILLERS CHRISTOPH

申请号：

CL2012003282

公开号：

CL2012003282A1

申请日:

2012.11.23

申请国别(地区):

CL

年份:

2013

代理人:

摘要：

Topical Pharmaceutical composition comprising, based on the total weight of the composition (a) 0.01 to 0.2% by weight of Mometasone furoate (b) 5 to 18% by weight of hexylene glycol.(c) 20 to 40 Weight percent of water and (d) 25 to 70% by weight of an oil Phase； and its use to Treat or prevent psoriasis, atopic dermatitis, among others.Composición farmacéutica tópica que comprende, en base al peso total de la composición A) 0,01 a 0,2 % en peso de furoato de mometasona, B) 5 a 18 % en peso de hexilenglicol, C) 20 a 40 % en peso de agua y D) 25 a 70 % en peso de una fase oleosa； y su uso para tratar o prevenir psoriasis, dermatitis atópica, entre otros.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/